Home > Press > BNC secures largest contract to date
Abstract:
The specialist product development consultancy, Bio Nano Consulting (BNC) is pleased to announce that it has recently signed its largest contract to date with a major chemical company. BNC has secured this contract as a result of unique intellectual property developed at its partner institutions of Imperial College and the London Centre for Nanotechnology. The 12 month project aims to provide a consistent system for the separation of single walled carbon nanotubes (SWNTs) based on their electrical properties for improved micro-electronic performance. The work by BNC will develop the processes to a sufficient maturity to allow the client to license and further commercialise the technology.
The separation of SWNTs with well-defined chirality is the ‘holy grail' of nanotube science and the development of better manufacturing and process techniques is vital to the future of carbon nanotechnology. Possible applications for Metallic SWNTs are indium tin oxide (ITO) replacement, electromagnetic interference (EMI) shielding, electrodes, field emission devices and transmission cables. In contrast, semiconducting nanotubes could be used in applications such as nanoelectronics, sensors, non-linear optical (NLO) devices, active components in photovoltaics, organic electronics, printed electronics and thin film transistors.
Delivering innovative solutions to industry across the life-science and technology sectors, BNC are able to effectively address real-world problems with nanotechnology based solutions. "With our traditional focus being the pharmaceutical, medical and bio-tech industries, we are delighted to have signed our second contract looking at advancing electronic technologies." commented Dr David Sarphie, CEO of BNC. He continued, "It is great news that our world-class technology and expertise has successfully extended across into this critical sector."
####
About Bio Nano Consulting (BNC)
The BNC is a specialist research and development consultancy operating in the convergent field of bionanotechnology. A joint venture of Imperial College London and University College London, the BNC is funded through the Technology Strategy Board (TSB) with additional support from the London Development Agency (LDA).
Along with its partner organisation, the National Physical Laboratory, the BNC offers a service to the biomedical and healthcare industries in microsystems and nanotechnology. This encompasses design, 3-D modelling and visualisation, rapid prototyping, and characterisation.
For more information, please click here
Contacts:
Product Enquiries
Bio Nano Consulting
Dr Mike Fisher
Business Development Director
BNC
t: +44 (0)207 268 3330
Media enquiries
Alto Marketing Limited
Neil Ravenhill
Scientific Communications Manager
t: +44 (0)1489 557672
Copyright © Bio Nano Consulting (BNC)
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanotubes/Buckyballs/Fullerenes/Nanorods/Nanostrings
Tests find no free-standing nanotubes released from tire tread wear September 8th, 2023
Detection of bacteria and viruses with fluorescent nanotubes July 21st, 2023
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||